Aperçu rapide pour Wilms Tumor 1 (WT1) (Middle Region) Peptide (ABIN986235)
Antigène
WT1
(Wilms Tumor 1 (WT1))
Origine
Humain
Source
Synthetic
Application
Western Blotting (WB), Blocking Peptide (BP), Immunohistochemistry (IHC)
Protein Region
Middle Region
Attributs du produit
This is a synthetic peptide designed for use in combination with anti-WT1 antibody (Catalog #: ARP37989_P050). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
Each Investigator should determine their own optimal working dilution for specific applications.
Restrictions
For Research Use only
Format
Lyophilized
Reconstitution
Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
Concentration
1 mg/mL
Buffer
Final peptide concentration is 1 mg/mL in PBS.
Conseil sur la manipulation
Avoid repeated freeze-thaw cycles.
Stock
-20 °C
Stockage commentaire
For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
Antigène
WT1
(Wilms Tumor 1 (WT1))
Sujet
WT1 is a transcription factor that contains four zinc-finger motifs at the C-terminus and a proline/glutamine-rich DNA-binding domain at the N-terminus. It has an essential role in the normal development of the urogenital system, and it is mutated in a sm
Alias Symbols: GUD, WAGR, WIT-2, WT33, AWT1, NPHS4, EWS-WT1
Protein Interaction Partner: AREG,CIAO1,CREBBP,FHL2,PAWR,PAX2,PRKACA,TP53,TP63,TP73,U2AF2,UBE2I,WTAP,WTIP,PAWR,Pawr,TP53,U2AF2,UBE2I,WTAP